Sartorius Aktiengesellschaft (SRT) - Total Assets
Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT) holds total assets worth €9.87 Billion EUR (≈ $11.54 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sartorius Aktiengesellschaft - Total Assets Trend (2013–2025)
This chart illustrates how Sartorius Aktiengesellschaft's total assets have evolved over time, based on quarterly financial data. Also see SRT stock market capitalisation for the company's overall valuation and market capitalisation.
Sartorius Aktiengesellschaft - Asset Composition Analysis
Current Asset Composition (December 2025)
Sartorius Aktiengesellschaft's total assets of €9.87 Billion consist of 18.2% current assets and 81.8% non-current assets. Review Sartorius Aktiengesellschaft debt and liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 5.6% |
| Accounts Receivable | €224.70 Million | 2.3% |
| Inventory | €792.20 Million | 8.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.83 Billion | 18.8% |
| Goodwill | €3.47 Billion | 35.7% |
Asset Composition Trend (2013–2025)
This chart illustrates how Sartorius Aktiengesellschaft's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See SRT stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sartorius Aktiengesellschaft's current assets represent 18.2% of total assets in 2025, a decrease from 31.2% in 2013.
- Cash Position: Cash and equivalents constituted 5.6% of total assets in 2025, up from 4.4% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 53.0% of total assets, an increase from 43.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 35.7% of total assets.
Sartorius Aktiengesellschaft Competitors by Total Assets
Key competitors of Sartorius Aktiengesellschaft based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Sartorius Aktiengesellschaft - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.91 | 1.46 | 1.33 |
| Quick Ratio | 0.52 | 0.93 | 0.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-189.80 Million | €678.10 Million | €361.80 Million |
Sartorius Aktiengesellschaft - Advanced Valuation Insights
This section examines the relationship between Sartorius Aktiengesellschaft's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.43 |
| Latest Market Cap to Assets Ratio | 0.75 |
| Asset Growth Rate (YoY) | -3.8% |
| Total Assets | €9.72 Billion |
| Market Capitalization | $7.26 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Sartorius Aktiengesellschaft's assets below their book value (0.75x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Sartorius Aktiengesellschaft's assets decreased by 3.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Sartorius Aktiengesellschaft (2013–2025)
The table below shows the annual total assets of Sartorius Aktiengesellschaft from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €9.72 Billion ≈ $11.36 Billion |
-3.82% |
| 2024-12-31 | €10.10 Billion ≈ $11.81 Billion |
+3.67% |
| 2023-12-31 | €9.75 Billion ≈ $11.39 Billion |
+39.67% |
| 2022-12-31 | €6.98 Billion ≈ $8.16 Billion |
+22.46% |
| 2021-12-31 | €5.70 Billion ≈ $6.66 Billion |
+21.30% |
| 2020-12-31 | €4.70 Billion ≈ $5.49 Billion |
+65.15% |
| 2019-12-31 | €2.84 Billion ≈ $3.33 Billion |
+12.56% |
| 2018-12-31 | €2.53 Billion ≈ $2.95 Billion |
+9.97% |
| 2017-12-31 | €2.30 Billion ≈ $2.69 Billion |
+31.07% |
| 2016-12-31 | €1.75 Billion ≈ $2.05 Billion |
+21.97% |
| 2015-12-31 | €1.44 Billion ≈ $1.68 Billion |
+12.90% |
| 2014-12-31 | €1.27 Billion ≈ $1.49 Billion |
+7.76% |
| 2013-12-31 | €1.18 Billion ≈ $1.38 Billion |
-- |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more